Author

T. K. Maity

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biophysics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:proteomics· 3 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:imaging· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

C. M. Cultraro· 3 shared S. Gao· 3 shared U. Guha· 3 shared X. Zhang· 3 shared A. Venugopalan· 2 shared J. Khan· 2 shared K. D. Nguyen· 2 shared N. Roper· 2 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

C. M. Cultraro

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

BiophysicsbioRxivPreprintNov 14, 2023

YAP localization mediates mechanical adaptation of human cancer cells during extravasation in vivo

W. Y. So, C. S. Wong, U. F. Azubuike…·K. Tanner

This study investigates how YAP-mediated mechanogenotypes influence mechanical adaptation of cancer cells during extravasation and organ colonization in vivo.

DOI 10.1101/2023.11.14.567015

humanimaging

𝕏 PostBluesky

ImmunologybioRxivAug 4, 2020

Proteogenomic analysis unveils the HLA Class I presented immunopeptidome in melanoma and EGFR mutant lung adenocarcinoma

Y. A. Qi, T. K. Maity, C. M. Cultraro…·U. Guha

The paper identifies HLA Class I-presented peptides in melanoma and EGFR mutant lung adenocarcinoma using proteogenomic analysis, revealing neopeptides and post-translationally modified peptides for potential immunotherapy.

DOI 10.1016/j.mcpro.2021.100136

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivAug 22, 2018

Quantitative mass spectrometry to interrogate proteomic heterogeneity in metastatic lung adenocarcinoma and validate a novel somatic mutation CDK12-G879V

X. Zhang, K. D. Nguyen, P. Rudnick…·U. Guha

The paper uses quantitative mass spectrometry to analyze proteomic and phosphoproteomic changes in metastatic lung adenocarcinoma and validates a novel somatic mutation CDK12-G879V associated with chemotherapy sensitivity.

DOI 10.1074/mcp.ra118.001266

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivMay 11, 2018

Integrated proteogenomic analysis of metastatic thoracic tumors identifies APOBEC mutagenesis and copy number alterations as drivers of proteogenomic tumor evolution and heterogeneity

N. Roper, S. Gao, T. K. Maity…·U. Guha

DOI 10.1016/j.celrep.2019.02.028

humanwhole-exome sequencing

𝕏 PostBluesky